Study guide

5.1 Kawasaki Disease & Pediatric Coronary Aneurysm Surveillance

ARDMS Pediatric Echocardiography RDCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Normal Great Arteries & Coronary Origins

1.1 Aortic Arch, Branching Patterns & Conotruncal Anatomy 1.2 Normal Coronary Artery Anatomy, Origins & Variants 1.3 Pulmonary Artery Branching & Ductus Arteriosus Geometry

2 Chapter 2: Systemic and Pulmonary Veins & Cardiac Chambers

2.1 Systemic Venous Connections: IVC, SVC, Hepatic Veins & Coronary Sinus 2.2 Pulmonary Venous Drainage, Left Atrium & Ridge Anatomy 2.3 Right and Left Ventricular Anatomy & Morphologic Characteristics

3 Chapter 3: Cardiac Valves, Transitional Circulation & Situs

3.1 Atrioventricular and Semilunar Valve Morphology & Subvalvular Apparatus 3.2 Fetal to Neonatal Transitional Circulation, Persistent Fetal Shunts & Visceral Situs

4 Chapter 4: Pediatric Cardiomyopathies & Cardiotoxicity

4.1 Hypertrophic and Restrictive Cardiomyopathy in Children 4.2 Dilated, Non-Compaction & Arrhythmogenic Ventricular Cardiomyopathies 4.3 Anthracycline Cardiotoxicity, Neuromuscular Dystrophies & Metabolic Infiltration

5 Chapter 5: Inflammatory, Hypertensive & Systemic Acquired Conditions

5.1 Kawasaki Disease & Pediatric Coronary Aneurysm Surveillance 5.2 Infective Endocarditis, Rheumatic Heart Disease & Pericardial Effusion 5.3 Pediatric Pulmonary Arterial Hypertension, Cor Pulmonale & Eisenmenger Syndrome 5.4 Systemic Hypertension & Hypertensive Heart Disease in Children 5.5 Heritable Connective Tissue Disorders & Pediatric Aortopathy

6 Chapter 6: Septal Defects & Atrioventricular Canal Anomalies

6.1 Atrial Septal Defects: Secundum, Primum, Sinus Venosus & Unroofed Coronary Sinus 6.2 Ventricular Septal Defects: Membranous, Muscular, Inlet & Malalignment 6.3 Complete, Partial & Transitional Atrioventricular Canal (AV Septal) Defects

7 Chapter 7: Conotruncal Anomalies & Outflow Malformations

7.1 Tetralogy of Fallot, Absent Pulmonary Valve & Pulmonary Atresia with VSD 7.2 D-Transposition of the Great Arteries & L-Transposition (ccTGA) 7.3 Truncus Arteriosus, Double Outlet Right Ventricle (DORV) & Aortopulmonary Window

8 Chapter 8: Left and Right Heart Obstructive & Valvular Defects

8.1 Coarctation of the Aorta, Interrupted Aortic Arch & Shone Complex 8.2 Aortic Valve Stenosis, Subaortic Membranes, Supravalvular AS & Bicuspid Aorta 8.3 Ebstein Anomaly, Tricuspid Dysplasia & Congenital Pulmonary Stenosis/Atresia

9 Chapter 9: Venous & Ductal Anomalies, Coronaries, Single Ventricle, Cardiac Masses & Genetic Syndromes

9.1 Total & Partial Anomalous Pulmonary Venous Connection (TAPVC/PAPVC) 9.2 Patent Ductus Arteriosus & Vascular Rings / Slings 9.3 Anomalous Coronary Origins: ALCAPA, ARCAPA, Course & Fistulas 9.4 Hypoplastic Left Heart Syndrome (HLHS) & Tricuspid Atresia Anatomy 9.5 Cardiac Tumors & Intracardiac Masses in Children 9.6 Cor Triatriatum, Systemic Venous Anomalies & Heterotaxy Syndromes 9.7 Genetic Syndromes & Their Associated Cardiac Lesions

10 Chapter 10: Surgical Repair of Septal Defects, TOF & Arch Lesions

10.1 Postoperative ASD, VSD & AV Canal Repair Assessment 10.2 Postoperative Tetralogy of Fallot Repair & Pulmonary Valve Replacement 10.3 Postoperative Coarctation Repair, Arch Reconstruction & Residual Gradients

11 Chapter 11: Great Artery Switches, Baffles & Conduit Operations

11.1 Arterial Switch Operation (Jatene) & Lecompte Maneuver Evaluation 11.2 Atrial Inversion Baffles (Mustard/Senning) & Rastelli Repair 11.3 Right Ventricle to Pulmonary Artery (RV-PA) Conduits & Ross Procedure

12 Chapter 12: Single Ventricle Palliation, TAPVC Repair, Transplants & Devices

12.1 Norwood Stage I Reconstruction, Sano Shunts & Blalock-Taussig Shunts 12.2 Superior Cavopulmonary Connection (Bidirectional Glenn / Hemi-Fontan) 12.3 Total Cavopulmonary Connection (Fontan Completion: Extracardiac & Lateral Tunnel) 12.4 Postoperative TAPVC Repair, Pediatric Heart Transplantation & Ventricular Assist Devices 12.5 Implantable Devices, Lines & Lead-Related Echocardiographic Findings 12.6 Transcatheter Interventions: Balloon Valvuloplasty, Stents & Valve Implantation

13 Chapter 13: Acoustic Windows, Instrumentation & Pediatric Ergonomics

13.1 Standard Pediatric Acoustic Windows & Subcostal / Suprasternal Views 13.2 Transducer Selection, High Frequency Probes, Frame Rates & Pediatric Ergonomics 13.3 Patient Immobilization, Pediatric Sedation Protocols & Safety Considerations

14 Chapter 14: Doppler Hemodynamics, Bernoulli & Shunt Evaluation

14.1 Modified Bernoulli Equation, Peak vs Mean Gradients & Continuity Equation 14.2 Pulmonary-to-Systemic Flow Ratio (Qp:Qs) Calculations & Shunt Direction 14.3 Right Ventricular Systolic Pressure (RVSP) & Pulmonary Artery Pressure Estimation

15 Chapter 15: Chamber Quantification, Systolic & Diastolic Assessment

15.1 Pediatric Z-Score Methodology & BSA Indexing (Haycock/DuBois) 15.2 Left Ventricular Systolic Function: Simpson Biplane, 5/6 Area x Length & FS 15.3 Right Ventricular Quantitative Function: TAPSE, FAC & Tissue Doppler S' 15.4 Pediatric Diastolic Function Assessment: Mitral Inflow, Tissue Doppler & E/e'

16 Chapter 16: Advanced Modalities: Strain, 3D Echo & Saline Studies

16.1 Speckle Tracking Echocardiography & Global Longitudinal Strain (GLS) 16.2 Real-Time 3D Pediatric Echocardiography: En Face Valvular Imaging & Volume Assessment 16.3 Agitated Saline Bubble Studies, Ultrasound Enhancing Agents & Shunt Timing 16.4 Transesophageal (TEE) & Epicardial Echocardiography in Congenital Heart Surgery

5.1 Kawasaki Disease & Pediatric Coronary Aneurysm Surveillance

Key Takeaways Explain This Topic AI

Kawasaki disease (KD) is an acute, self-limited medium-vessel necrotizing vasculitis that causes coronary artery aneurysms in up to 25% of untreated children, dropping to less than 5% with timely intravenous immunoglobulin (IVIG, 2 g/kg) and high-dose aspirin administered within the first 10 days of fever onset.

Clinical diagnosis requires persistent fever for at least 5 days plus at least 4 of 5 classic clinical criteria: bilateral non-exudative bulbar conjunctival injection with perilimbal sparing, polymorphous rash, cervical lymphadenopathy (>1.5 cm, usually unilateral), oral mucosal erythema (strawberry tongue, cracked lips), and extremity changes (acute induration/erythema; convalescent periungual desquamation).

Incomplete (atypical) Kawasaki disease is common in infants under 6 months of age, who paradoxically face the highest risk of giant coronary aneurysms; clinical guidelines mandate urgent echocardiography when unexplained fever of 5 or more days is accompanied by elevated CRP (>=3.0 mg/dL) or ESR (>=40 mm/hr) and supportive laboratory criteria.

Multisystem Inflammatory Syndrome in Children (MIS-C) presents 2 to 6 weeks following SARS-CoV-2 infection in older children (median age 8-11 years) with cardiogenic shock, profound left ventricular systolic depression, and transient mild coronary ectasia, contrasting with the focal structural aneurysms characteristic of classic infant/toddler KD.

Quantitative coronary surveillance mandates body surface area (BSA)-adjusted Z-scores (AHA guidelines): normal (<2.0), dilation only (2.0 to <2.5), small aneurysm (2.5 to <5.0), medium aneurysm (5.0 to <10.0 and absolute dimension <8 mm), and giant aneurysm (>=10.0 or absolute dimension >=8 mm), measured inner-edge to inner-edge at end-diastole while strictly excluding the perivascular adventitial halo.

Last updated: September 2026

5.1 Kawasaki Disease & Pediatric Coronary Aneurysm Surveillance

Clinical Core: Kawasaki disease (KD) is the leading cause of acquired pediatric heart disease in developed nations. Its most dangerous consequence—coronary artery vasculitis leading to ectasia, aneurysm formation, thrombosis, and myocardial infarction—is largely preventable if recognized and treated promptly with high-dose intravenous immunoglobulin (IVIG) and aspirin within the first 10 days of fever. The pediatric cardiac sonographer plays a central role in early detection, risk stratification via body surface area (BSA)-adjusted Z-scores, and longitudinal surveillance for ischemic complications.

Pathophysiology & Histopathologic Progression

Kawasaki disease is an acute, self-limited systemic vasculitis that predilects medium-sized muscular arteries, with an exquisite tropism for the coronary arterial tree. The underlying vascular inflammatory cascade evolves through three distinct histopathologic phases:

Acute Necrotizing Arteritis (Days 1 to 9): Marked by intense neutrophilic infiltration that initiates in the adventitia and media before rapidly invading the intima. This aggressive infiltration destroys the internal elastic lamina, degrades the structural smooth muscle media, and produces acute endothelial necrosis. During this early phase, two-dimensional echocardiography demonstrates perivascular brightness and subtle ectasia without fully formed aneurysms.

Subacute / Chronic Vasculitis (Days 10 to 25): The neutrophilic infiltrate transitions to a dense mononuclear infiltrate composed of CD8+ T lymphocytes, IgA-producing plasma cells, and macrophages. As matrix metalloproteinases degrade collagen and elastin fibers, the arterial wall loses structural integrity and balloons outward under systemic arterial pressure, resulting in true aneurysm formation. The subacute phase carries the highest risk of rapid aneurysm expansion, sudden thrombosis, and death.

Luminal Myofibroblastic Proliferation & Remodeling (Weeks to Years): Chronic inflammation gives way to vigorous proliferation of smooth muscle cells and myofibroblasts within the intima. While some small aneurysms appear to regress or normalize in caliber on two-dimensional imaging, this "angiographic regression" is actually an active fibrointimal scar. Progressive luminal myofibroblastic stenosis, calcification, and tortuosity frequently develop, especially at the entry and exit orifices of previous aneurysms. [Neutrophilic Infiltration] --> Destroys internal elastic lamina (Days 1-9)

  • │
  • [Mononuclear Infiltration] --> Media structural degradation & Aneurysm formation (Days 10-25)
  • │
  • [Myofibroblastic Proliferation]--> Intimal thickening, calcification & Stenosis (Months-Years)
  • Clinical Diagnostic Criteria: Classic vs. Incomplete Kawasaki Disease

Because there is no definitive single laboratory test, Kawasaki disease remains a clinical diagnosis supported by echocardiography and inflammatory biomarkers.

Classic Diagnostic Criteria

The diagnostic standard requires persistent high fever for at least 5 days (unresponsive to standard antipyretics or antibiotics) plus at least 4 of the following 5 principal clinical features :

Bilateral Bulbar Conjunctival Injection: Painless, non-exudative conjunctivitis with characteristic perilimbal sparing (a pale ring around the cornea).

Oral Mucosal Changes: Intense erythema and cracking/bleeding of the lips, diffuse pharyngeal erythema, and prominent hypertrophied lingual papillae ("strawberry tongue").

Cervical Lymphadenopathy: Usually unilateral, firm, non-suppurative, involving at least one lymph node measuring >1.5 cm in diameter.

Polymorphous Exanthem: Maculopapular, diffuse scarlatiniform, or erythema multiforme-like rash; characteristically prominent in the groin/perineal area; never vesicular or bullous.

Extremity Changes: Acute phase: intense erythema of the palms and soles, accompanied by indurative, non-pitting edema of the dorsum of the hands and feet. Convalescent phase (weeks 2–3): characteristic periungual sheet-like desquamation (peeling around fingernails and toenails).

Incomplete (Atypical) Kawasaki Disease

Incomplete KD occurs when patients exhibit prolonged unexplained fever (>=5 days) but satisfy fewer than 4 principal criteria. This presentation is exceptionally common in infants younger than 6 months of age , who paradoxically face the highest risk of developing giant coronary aneurysms due to delayed diagnosis. The American Heart Association (AHA) algorithm recommends advancing to echocardiography if an infant has fever >=5 days and systemic inflammatory markers are elevated (C-reactive protein [CRP] >=3.0 mg/dL or erythrocyte sedimentation rate [ESR] >=40 mm/hr), accompanied by at least 3 supportive laboratory features:

  • Anemia for age (normocytic, normochromic)
  • Platelet count >450,000/μL after day 7 of fever
  • Hypoalbuminemia (<3.0 g/dL)
  • Elevated serum alanine aminotransferase (ALT)
  • Leukocytosis (white blood cell count >=15,000/μL)
  • Sterile pyuria (>=10 WBC/high-power field in clean-catch urine)
  • Multisystem Inflammatory Syndrome in Children (MIS-C) vs. Classic KD

Following the COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) emerged as a distinct post-viral hyperinflammatory entity sharing features with Kawasaki disease. Recognizing key clinical and echocardiographic differences is essential for the pediatric sonographer:

Diagnostic Feature Classic Kawasaki Disease (KD) Multisystem Inflammatory Syndrome in Children (MIS-C)

Patient Demographics Young children (<5 years; peak 18–24 months) Older children and adolescents (median age 8–11 years)

Antecedent Trigger Unknown infectious/environmental trigger SARS-CoV-2 infection/exposure (2 to 6 weeks prior)

Dominant Presentation Mucocutaneous signs, high fever, irritability Severe gastrointestinal pain, vomiting, diarrhea, neurocognitive signs

Hemodynamic Shock Infrequent (KD Shock Syndrome in <5%) Very common (50–70% present with warm vasodilatory/cardiogenic shock)

Myocardial Involvement Mild subclinical myocarditis (normal or mild EF drop) Severe acute fulminant myocarditis; marked LV systolic/diastolic depression

Biomarker Elevation Elevated CRP/ESR; thrombocytosis (>450,000/μL) Massive elevation of NT-proBNP, Troponin I/T, Ferritin, D-dimer; lymphopenia

Coronary Arteries Focal saccular or fusiform aneurysms (up to giant size) Transient, diffuse mild-to-moderate dilation (Z-score 2.0–3.5); giant aneurysms exceedingly rare

Coronary Natural History Long-term remodeling, calcification, stenosis risk Rapid normalization of coronary caliber and LV EF within 2 to 8 weeks

Pediatric Echocardiographic Coronary Examination Protocol

Imaging the coronary arteries in neonates and young children demands high-frequency transducers (8–12 MHz in infants, 5–8 MHz in older children), high frame rates (>50 Hz), minimized color Doppler velocity scales (20–40 cm/s) to prevent color blooming, and meticulous transducer sweeps across multiple acoustic windows.

Systematic Segmental Interrogation

Left Main Coronary Artery (LMCA): Identified originating from the left (posterior) coronary sinus at approximately the 4 to 5 o'clock position on the parasternal short-axis (PSAX) aortic valve view. The sonographer must track the LMCA from its ostium to its bifurcation into the LAD and LCx.

Left Anterior Descending (LAD): Best evaluated by tilting slightly superiorly and anteriorly from the PSAX view, profiling its origin and proximal course down the anterior interventricular groove. Modified parasternal long-axis (PLAX) and apical two-chamber sweeps track its mid-to-distal segments toward the cardiac apex.

Left Circumflex (LCx): Branches laterally from the LMCA and courses posteriorly within the left atrioventricular groove. It is imaged in PSAX by sweeping posteriorly, as well as in modified apical four-chamber views.

Right Coronary Artery (RCA): Arises from the anterior right coronary sinus at the 10 to 11 o'clock position in PSAX. The proximal RCA is profiled originating from the sinus; tilting laterally and inferiorly reveals the mid-RCA coursing down the right AV groove. A modified RV inflow-outflow view and subcostal coronal/sagittal views provide elongated profiles of the mid-to-distal RCA, continuing to the posterior descending artery (PDA). [PSAX Aortic Base]

  • / \
  • [10-11 o'clock] [4-5 o'clock]
  • │ │
  • [RCA] [LMCA]
  • │ / \
  • [AV Groove] [LAD] [LCx]
  • │ │ │
  • [Mid-Distal/PDA] [AIVG] [Left AV Groove]
  • Measurement Technique

Coronary luminal dimensions must be measured during end-diastole (at the onset of the QRS complex) from inner-edge to inner-edge at the widest segment of the vessel. The sonographer must never include the echogenic perivascular adventitial border within the luminal caliper measurement.

Quantitative Coronary Assessment: AHA Z-Score Classification

Because absolute coronary dimensions vary dramatically across somatic growth, pediatric cardiology mandates the use of body surface area (BSA)-adjusted Z-scores (based on multicenter pediatric datasets such as Boston, Dallaire, or Olivieri). The AHA classifies coronary involvement into five distinct tiers:

Classification Category Coronary Dimension / Z-Score Criteria Structural Characteristics Clinical Significance & Management

1. No Involvement Z-score < 2.0 throughout Normal tapering, normal caliber Standard IVIG (2 g/kg) + aspirin; repeat echo at 1–2 and 4–6 weeks

2. Dilation Only Z-score 2.0 to < 2.5 Mild generalized ectasia or lack of distal tapering High risk of progression; repeat echo within 1 week to check for aneurysm expansion

3. Small Aneurysm Z-score 2.5 to < 5.0 Focal saccular or fusiform dilatation Aspirin monotherapy (3–5 mg/kg/day) until regression documented; low risk of acute infarction

4. Medium Aneurysm Z-score 5.0 to < 10.0 AND absolute dimension < 8 mm Distinct aneurysm sac; localized wall remodeling Dual antiplatelet therapy or aspirin + systemic anticoagulation; longitudinal stress imaging

5. Giant / Large Aneurysm Z-score >= 10.0 OR absolute dimension >= 8 mm Massive saccular expansion; flow stasis; intraluminal layering Highest risk of thrombosis and rupture; systemic anticoagulation (warfarin or LMWH) + aspirin

Morphological Distinction: Saccular vs. Fusiform

Saccular Aneurysms: Display an abrupt, spherical dilatation whose transverse diameter markedly exceeds its longitudinal length. They create profound local vortices, low shear stress, and blood stasis, predisposing to acute intraluminal thrombosis .

Fusiform Aneurysms: Demonstrate gradual, spindle-shaped, symmetric tapering along the vessel length. Although less prone to acute occlusive thrombosis than saccular variants, they frequently undergo extensive concentric myofibroblastic intimal proliferation over time, resulting in calcific luminal stenosis .

Clinical Complications & Associated Echocardiographic Findings

Beyond coronary arterial enlargement, acute vasculitis induces multisystem intracardiac pathology:

Intraluminal Coronary Thrombosis: Appears as an echogenic mass within the aneurysmal lumen, producing partial flow occlusion or complete non-visualization of distal color flow. Thrombosis precipitates acute ST-segment elevation myocardial infarction (STEMI) or sudden cardiac arrest.

Coronary Stenosis: Manifests as focal luminal narrowing with high-velocity, turbulent, aliasing flow on color and pulsed-wave Doppler, most frequently situated at the inlet or outlet orifices of previous medium or giant aneurysms.

Myocardial Infarction: Identified by regional wall motion abnormalities (hypokinesis, akinesis, or paradoxical dyskinesis), myocardial wall thinning, and hyperrefractive fibroelastosis of ischemic papillary muscles.

Acute Myocarditis: Present in >50% of acute KD cases, manifesting as transient global left ventricular systolic dysfunction (fractional shortening <28%, ejection fraction <50%), accompanied by ventricular dilation.

Mitral Regurgitation: Typically mild to moderate, resulting from acute papillary muscle ischemia or transient valvulitis with annular dilation.

Pericardial Effusion: Present in 30% of patients during the acute phase; usually small to moderate and serous; cardiac tamponade is exceedingly rare.

Aortic Root Dilation: Mild, subclinical ectasia of the aortic annulus and sinuses of Valsalva (Z-scores +2.0 to +3.5) occurs in ~10% of patients due to systemic elastin degradation.

Clinical Pearls & Diagnostic Traps

Warning

The Perivascular Brightness Trap: In early Kawasaki disease, perivascular adventitial brightness (hyperechoic cuffing surrounding the coronary vessels) is a recognized subjective marker of active arteritis. However, sonographers must NEVER include this bright adventitia in vessel measurements. Measuring from outer-to-outer border will falsely overestimate coronary dimensions, converting a normal vessel into a pseudo-aneurysm.

Important

The Infant Vulnerability Window: Any infant under 6 months of age with unexplained fever lasting >=5 days must undergo urgent pediatric echocardiography, even in the complete absence of conjunctivitis, rash, or lymphadenopathy. Over 50% of infants with KD present with incomplete criteria and experience disproportionately high rates of giant coronary aneurysms.

Tip

Color Doppler Optimization: Standard color velocity scales (50–70 cm/s) cause severe color blooming that obscures the true vessel lumen. Always reduce the color Doppler Nyquist limit to 20–35 cm/s and decrease the color gain until background speckle disappears, ensuring clear delineation between intraluminal flow and the endoluminal wall.

Loading diagram... Kawasaki Disease Coronary Evaluation & Z-Score Stratification